NCT05482828

Effect of Jaeumgeonbi-Tang on Chronic Subjective Dizziness

Effect of Jaeumgeonbi-Tang on Chronic Subjective Dizziness: A Randomized, Double-Blind, Parallel-group, Placebo-Controlled Trial

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Korea Health Industry Development Institute · Other Government
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The goal of this study is to assess the safety and efficacy of JGT (Jaeumgeonbi-Tang). A randomized, double-blind, parallel-group, placebo-controlled clinical trial was conducted and changes in symptoms and quality of life of the patients were evaluated.

Detailed description

This study's protocol was designed to assess the efficacy of JGT (Jaeumgeonbi-Tang) for chronic subjective dizziness. * This design of the study is a randomized, double-blind, parallel-group, placebo-controlled design. * Symptoms and quality of life of chronic subjective dizziness patients will be evaluated. * Dizziness severity and quality of life of the patients will be evaluated using DHI (Dizziness Handicap Inventory) (1) before treatment (baseline), (2) after 2 weeks, and (3) after 4 weeks of JGT treatment. * Blood samples of the patients will be gathered before and after JGT treatment for pathophysiological analysis.

Conditions

• Chronic Subjective Dizziness

Interventions

Type	Name	Description
DRUG	JGT (Jaeumgeonbi-Tang) tablet	JGT tablet (composed of 19 herbs), 24 g daily (single dose=8 g), t.i.d. for 28 days
DRUG	Placebo tablet	Corn starch tablet, 24 g daily (single dose=8 g), t.i.d. for 28 days

Timeline

• Start date: 2010-05-01
• Primary completion: 2011-12-01
• Completion: 2013-12-31
• First posted: 2022-08-01
• Last updated: 2023-10-10

Locations

1 site across 1 country: South Korea